MAM
ONC

Morse Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Morse Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
1,378
-70
-5% -$20.6K 0.07% 139
2026
Q1 		$430K Buy
1,448
+1,428
+7,140% +$462K 0.09% 129
2025
Q4 		$6.08K Buy
+20
New +$6.55K ﹤0.01% 312

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morse Asset Management's ONC Position: Q2 2026 in Review

Morse Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 4.8% in Q2 2026, selling an estimated $20.6K and leaving 1,378 shares worth $393K. The position accounts for 0.07% of the portfolio, ranked #139.

Morse Asset Management first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $430K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Morse Asset Management held 1,378 shares of BeOne Medicines Ltd worth $393K as of Q2 2026.
  • Morse Asset Management sold 70 BeOne Medicines Ltd shares in Q2 2026, an estimated $20.6K.
  • BeOne Medicines Ltd made up 0.07% of Morse Asset Management's portfolio in Q2 2026, its #139 holding.
  • Morse Asset Management first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • Morse Asset Management's BeOne Medicines Ltd position peaked at $430K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.